High-dose Norepinephrine Treatment

 November 10

by Jonathan Downham

High-dose Norepinephrine Treatment

In conclusion, high 28-day mortality of critically ill patients with shock who received high-dose norepinephrine in the ICU does not seem to be associated with underlying disease and comorbid conditions, the cause of shock, or dose or duration of norepinephrine treatment. However, our data suggest that treatment with norepinephrine is futile in patients with high disease severity, metabolic acidemia, and need for cotreatment with high doses of epinephrine. Our results may be helpful in future end-of-life decisions, at least in our ICU..link here
 Previous Article
Next Article

share this

Related Posts

Hypophosphatemia in Critical Care

Summary:In this episode, we spotlight a stealthy ICU disruptor — hypophosphataemia. Based on a 2024 narrative review in the Journal of Clinical Medicine, we explore why phosphate matters, how it goes missing in critically ill patients, and why you should care even when it’s just “a little low.”What’s Covered:The vital role of phosphate in energy,

Read More

Mobilisation in Critical Care- Barriers and Culture

Mobilisation in the ICU raises two big questions: is it safe, and will staff embrace it?In this discussion, Jonathan explores both sides of the story:Safety first:Large prevalence studies show mobilisation is happening, though often inconsistently.A systematic review of 1,800+ sessions found serious adverse events in only 0.6% — most minor and short-lived.Even patients on CRRT can safely mobilise

Read More